Home › Tumori cerebrali › North Carolina › Durham
Studi clinici su Tumori cerebrali a Durham, NC
14 studi su Tumori cerebrali cercano partecipanti presso sedi a Durham e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
In reclutamentoFase 1/2
- Duke University School of Medicine, Durham
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
In reclutamentoFase 2
- Local Institution - 0100, Durham
A Phase 1/1b Study of IAM1363 in HER2 Cancers
In reclutamentoFase 1
- Duke Cancer Institute, Durham
Targeted Pediatric High-Grade Glioma Therapy
In reclutamentoStudio osservazionale
- Duke University Health System, Durham
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
In reclutamentoFase 2
- Duke University, Durham
Study of Olutasidenib and Temozolomide in HGG
In reclutamentoFase 2
- Duke University Health System, Durham
ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas
In reclutamentoFase 1
- Duke University Medical Center, Durham
MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets
In reclutamentoStudio osservazionale
- University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill · a 10 mi di distanza
B6 Administration for Levetiracetam-Associated Neurobehavioral Changes and Epilepsy
In reclutamento
- Duke University Medical Center, Durham
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
In reclutamentoFase 2
- Duke University Health System, Durham
Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
In reclutamentoFase 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · a 10 mi di distanza
Key Longitudinal Associations With Risk and Glioblastoma Outcomes
In reclutamentoStudio osservazionale
- Duke University, Durham
Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors
In reclutamentoStudio osservazionale
- Duke Cancer Center, Durham
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
In reclutamentoFase 2
- University of North Carolina, Chapel Hill · a 10 mi di distanza
Studi su Tumori cerebrali in altre città
- Houston, TX35 studi
- Boston, MA28 studi
- New York City, NY25 studi
- Washington, DC20 studi
- Los Angeles, CA16 studi
- Miami, FL15 studi
- St. Louis, MO12 studi
- Cleveland, OH11 studi
- Seattle, WA11 studi
- Rochester, MN11 studi
- Baltimore, MD11 studi
- Columbus, OH11 studi
Altri studi a Durham
- Cancro al seno63 studi
- Cancro (tutti i tipi)58 studi
- Cancro del polmone non a piccole cellule39 studi
- Mieloma multiplo37 studi
- Cancro metastatico33 studi
- Leucemia mieloide acuta33 studi
- Cancro ai polmoni32 studi
- Cancro alla prostata32 studi
- Cancro colorettale28 studi
- Leucemia linfatica cronica27 studi
- Cancro ovarico27 studi
- Insufficienza cardiaca26 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.